RNA targets of TDP-43: Which one is more important in neurodegeneration?
Authors:
Open Access
- 25 February 2022
- journal article
- editorial
- Published by Springer Nature in Translational Neurodegeneration
- Vol. 11 (1) , 1-3
Abstract
No abstract availableFunding Information
- National Institutes of Health (R37NS057553, R01NS101986)
This publication has 10 references indexed in Scilit:
- TDP-43 represses cryptic exon inclusion in the FTD–ALS gene UNC13ANature, 2022
- TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13ANature, 2022
- ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repairNature Neuroscience, 2019
- Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegenerationNature Neuroscience, 2019
- TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTDScience, 2015
- Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein HomeostasisNeuron, 2013
- TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegenerationHuman Molecular Genetics, 2010
- Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosisNature Genetics, 2009
- Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral SclerosisScience, 2006
- Aberrant Morphology and Residual Transmitter Release at the Munc13-Deficient Mouse Neuromuscular SynapseMolecular and Cellular Biology, 2005